Pembrolizumab is a humanized monoclonal antibody inhibiting the PD-1 receptor and the first in the class of agents called the HER2 dimerization inhibitors that impairs the ability of HER2 to bind to other members of the HER family.
Molecular Weight:
149 kDa
CAS Number:
[1374853-91-4]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
